Nevus anemicus and RASopathies

Charlotte Bulteel; Marie-Anne Morren; Petra De Haes; Ellen Denayer; Eric Legius; Hilde Brems

doi:10.1016/j.jdcr.2017.09.037

Nevus anemicus and RASopathies

JAAD Case Rep. 2018 Apr 6;4(4):390-391. doi: 10.1016/j.jdcr.2017.09.037. eCollection 2018 May.

Authors

Charlotte Bulteel^{1

2}, Marie-Anne Morren^{1

2}, Petra De Haes^{1

2}, Ellen Denayer³, Eric Legius^{3

4}, Hilde Brems^{3

4}

Affiliations

¹ Department of Dermatology, University Hospital Leuven, Leuven, Belgium.
² Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.
³ Department of Human Genetics, University Hospital Leuven, Leuven, Belgium.
⁴ Department of Human Genetics, KU Leuven, Leuven, Belgium.

No abstract available

Keywords: CALMs, café au lait macules; Legius syndrome; MAPK, mitogen-activated protein kinase; NF1, neurofibromatosis type 1; Noonan syndrome; PTPN11, protein tyrosine phosphatase nonreceptor type 11; RAF1, rapidly accelerated fibrosarcoma-1; RAS, rat sarcoma family of protooncogenes; RASopathy; SPRED1, sprouty-related, EVH1 domain containing protein 1; neurofibromatosis; nevus anemicus; α1-AR, α1-adrenergic receptors.

Publication types

Case Reports